Diana Bolotin to Middle Aged
This is a "connection" page, showing publications Diana Bolotin has written about Middle Aged.
Connection Strength
0.196
-
Histologic Status of Squamous Cell Carcinoma In Situ After Diagnostic Biopsy in Immunocompetent and Immunosuppressed Patients. Dermatol Surg. 2018 Mar; 44(3):341-349.
Score: 0.039
-
Giant cellulitis-like Sweet syndrome in the setting of autoimmune disease. J Am Acad Dermatol. 2014 Sep; 71(3):e94-5.
Score: 0.031
-
Cutaneous Churg-Strauss syndrome: response to dapsone therapy. J Am Acad Dermatol. 2011 Jul; 65(1):244-6.
Score: 0.025
-
Acquired combined nutritional deficiency presenting as psoriasiform dermatitis. J Am Acad Dermatol. 2010 Apr; 62(4):715-8.
Score: 0.023
-
How dermatologic surgeons decide to proceed with surgery for nonmelanoma skin cancer when site identification is initially uncertain: A nationwide, multicenter, prospective study. J Am Acad Dermatol. 2025 Jan; 92(1):85-91.
Score: 0.016
-
Outcomes of cutaneous surgery for nonmelanoma skin cancer in patients with different Fitzpatrick skin types: A nationwide, multicenter, prospective study. J Am Acad Dermatol. 2024 Jun; 90(6):1243-1245.
Score: 0.015
-
Acrochordon With Histological Features of Lichen Sclerosus. Am J Dermatopathol. 2019 Jun; 41(6):e64-e65.
Score: 0.011
-
Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillers. JAMA Dermatol. 2015 Mar; 151(3):271-7.
Score: 0.008
-
Treatment of keratosis pilaris with 810-nm diode laser: a randomized clinical trial. JAMA Dermatol. 2015 Feb; 151(2):187-91.
Score: 0.008
-
Treatment of forehead/glabellar rhytide complex with combination botulinum toxin a and hyaluronic acid versus botulinum toxin A injection alone: a split-face, rater-blinded, randomized control trial. J Cosmet Dermatol. 2013 Dec; 12(4):261-6.
Score: 0.007
-
The comparative effectiveness of suction-curettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: a randomized control trial. J Am Acad Dermatol. 2013 Jul; 69(1):88-95.
Score: 0.007
-
Safety of a novel microneedle device applied to facial skin: a subject- and rater-blinded, sham-controlled, randomized trial. Arch Dermatol. 2012 Jun; 148(6):711-7.
Score: 0.007